Hospital-based financial analysis of endovascular therapy and intravenous thrombolysis for large vessel acute ischemic strokes: the 'bottom line'.

scientific article

Hospital-based financial analysis of endovascular therapy and intravenous thrombolysis for large vessel acute ischemic strokes: the 'bottom line'. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/NEURINTSURG-2013-011085
P698PubMed publication ID24476964

P2093author name stringKim Evans
Ansaar T Rai
P2860cites workHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationQ22306356
Improved outcome prediction using CT angiography in addition to standard ischemic stroke assessment: results from the STOPStroke studyQ28732524
Endovascular therapy yields significantly superior outcomes for large vessel occlusions compared with intravenous thrombolysis: is it time to randomize?Q28950848
Heart disease and stroke statistics--2012 update: a report from the American Heart AssociationQ29547909
A trial of imaging selection and endovascular treatment for ischemic strokeQ30417276
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort studyQ33817793
Endovascular therapy after intravenous t-PA versus t-PA alone for strokeQ36837191
Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke.Q37158942
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic strokeQ37884297
Cost-effectiveness of endovascular therapy for acute ischemic strokeQ38046183
Measurement of length of hyperdense MCA sign in acute ischemic stroke predicts disappearance after IV tPA.Q40085640
Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcomeQ47973373
Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in CanadaQ48179233
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.Q48278361
Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler studyQ48351067
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupQ48480403
Hospitalization costs for acute ischemic stroke patients treated with intravenous thrombolysis in the United States are substantially higher than medicare paymentsQ48748123
Hospitalization costs for patients with acute ischemic stroke treated with endovascular embolectomy in the United StatesQ48857596
P433issue2
P921main subjectthrombolysisQ1931577
P304page(s)150-156
P577publication date2014-01-29
P1433published inJournal of NeuroInterventional SurgeryQ6295638
P1476titleHospital-based financial analysis of endovascular therapy and intravenous thrombolysis for large vessel acute ischemic strokes: the 'bottom line'.
P478volume7

Reverse relations

cites work (P2860)
Q38490419Accountable Care Organizations: what they mean for the country and for neurointerventionalists
Q38230006Comparison of endovascular treatment approaches for acute ischemic stroke: cost effectiveness, technical success, and clinical outcomes
Q39034824Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes
Q44564922Intravenous thrombolysis of large vessel occlusions is associated with higher hospital costs than small vessel strokes: a rationale for developing stroke severity-based financial models
Q36602310Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Health Technology Assessment
Q37066825Mechanical thrombectomy in patients with acute ischemic stroke: a cost-utility analysis
Q51298985Novel model of direct and indirect cost-benefit analysis of mechanical embolectomy over IV tPA for large vessel occlusions: a real-world dollar analysis based on improvements in mRS.
Q36859571The 'pit-crew' model for improving door-to-needle times in endovascular stroke therapy: a Six-Sigma project